Table 1

Association of Maspin expression to demographic, clinical, and pathological variables in 97 radical prostatectomy patients with no prior androgen ablation therapy

VariableTotal patientsMaspin expression% PositivePa
NegativePositive
Total97583940.2
Age0.317
 <55117436.4
 55–59124866.7
 60–6434211338.2
 65–692920931.0
 ≥70116545.5
Race0.121
 African-American22101254.6
 Caucasian75482736.0
WHO differentiation0.050
 Well3123825.8
 Moderate32181443.8
 Poor34171750.0
WHO nuclear grade0.108
 I37251232.4
 II58332543.1
 III202100.0
Gleason sum0.199
 3–596333.3
 654351935.2
 726131350.0
 8–984450.0
Pretreatment PSA0.765
 0–4117436.4
 4.1–10.052322038.5
 10.1–20.025141144.0
 ≥20.185337.5
 Unknown101
Pathological stage0.199
 pT242271535.7
 pT349272244.9
 pT4202100.0
 pTx642
  • a P for the Mantel-Haenszel χ2 test for trend in the association between Maspin expression and the levels of the variable. Pretreatment PSA = unknown and pathological stage = pTx were not included as levels in the trend tests.